New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them
Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, A and n are as defined in the description as B-cell lymphoma 2 (Bcl-2) inhibitors, pharmaceutical compositions thereof, and their use as pro-apoptotic agents and in the treatment of cancers.
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, A and n are as defined in the description as B-cell lymphoma 2 (Bcl-2) inhibitors, pharmaceutical compositions thereof, and their use as pro-apoptotic agents and in the treatment of cancers. |
---|---|
Bibliography: | Application Number: NZ20160738469 |